1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Jenburkt Pharmaceuticals
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
26.96% Fall from 52W High
-13.6
TTM PE Ratio
Below industry Median
14.1
Price to Book Ratio
Below industry Median
2.8
Dividend yield 1yr %
High in industry
1.5
TTM PEG Ratio
PEG TTM is less than 1
0.5
Jenburkt Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
1,016.60
10Day EMA
1,038.40
12Day EMA
1,047.20
20Day EMA
1,078.10
26Day EMA
1,096.20
50Day EMA
1,133.10
100Day EMA
1,126.70
200Day EMA
1,053.70
5Day SMA
1,006.10
10Day SMA
1,037.10
20Day SMA
1,083.20
30Day SMA
1,127.90
50Day SMA
1,174.60
100Day SMA
1,150.40
150Day SMA
1,110.30
200Day SMA
1,043.30
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 391 Rs | 439 Rs |
Week Rs | 3468 Rs | 3570 Rs |
Month Rs | 2061 Rs | 2478 Rs |
Resistance & Support
1,010.13
Pivot
Resistance
First Resistance
1,024.17
Second Resistance
1,044.03
Third Resistance
1,058.07
Support
First Support
990.27
Second support
976.23
Third Support
956.37
Relative Strength Index
37.47
Money Flow Index
57.57
MACD
-48.99
MACD Signal
-42.90
Average True Range
61.24
Average Directional Index
27.62
Rate of Change (21)
-17.63
Rate of Change (125)
-10.93
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
422.39 | 99.95 | 175.95 | ||
413.91 | 272.2 | 427.3 | ||
509.47 | 811.7 | 1752.95 | ||
Jenburkt Pharmaceuticals Ltd. | - | - | - | |
Kerala Ayurveda Ltd. | - | - | - | |
Zim Laboratories Ltd. | - | - | - | |
Accent Microcell Ltd. | - | - | - |
Jenburkt Pharmaceuticals Company background
Founded in: 1985
Managing director: Ashish U Bhuta
Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products.Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters to government, semigovernment institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at SihorGujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements. In addition, it has a Research Development unit duly approved by the Ministry of Science Technology, Government of India. Hence, the Company has strong manufacturing facilities to cater to domestic and international market.The purpose of the Company is to serve those in need of quality healthcare by bringing revolutionary, lifechanging therapeutic solutions that are accessible to all. Way back in the 20th century, a visionary in the field of healthcare and philanthropic work Shri Nandlal Mulji Bhuta laid the foundation for several groups of companies. Continuing the legacy of Shri Nandlal Mulji Bhuta, his sons Mr. Uttam N. Bhuta and Mr. Hemendra N. Bhuta founded the Company.In 202122, the Company launched a new OTC division Jenburkt Wellness towards better physical and mental health. The first brand launched was Zixa Strong, natural, pain relief product. Further, it launched Nervijen D3 tablets in 202223.
Jenburkt Pharmaceuticals FAQs
How to buy Jenburkt Pharmaceuticals shares?
You can easily buy Jenburkt Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
